<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02586181</url>
  </required_header>
  <id_info>
    <org_study_id>Vitamins and bone markers</org_study_id>
    <nct_id>NCT02586181</nct_id>
  </id_info>
  <brief_title>Effect of 1 Year Vitamin D or D Plus B-vitamins on Bone Markers in Elderly People (KnoVIB)</brief_title>
  <acronym>KnoVIB</acronym>
  <official_title>Effect of 1 Year Vitamin D or D Plus B-vitamins on Bone Markers in Elderly People</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saarland University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saarland University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The standard recommendation to prevent osteoporosis is to supplement low doses of vitamin D
      and calcium. Hyperhomocysteinemia has been related to increased risk of osteoporosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current study aimed at investigating if homocysteine-lowering effect (low doses of
      B-vitamins) will add any measurable beneficial effect on bone markers when added to the
      standard recommendations for prevention of osteoporosis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in bone formation markers</measure>
    <time_frame>baseline, 6 and 12 months</time_frame>
    <description>Concentrations of bone formation markers in plasma [OC (ng/ml), BAP (U/L)]: are measured: if all are increased indicate enhanced bone formation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in plasma choline and betaine</measure>
    <time_frame>baseline and aftter 12 months</time_frame>
    <description>plasma choline and betaine (all µmol/L): if both increased indicate saving betaine and choline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in global DNA methylation</measure>
    <time_frame>baseline and after 12 months</time_frame>
    <description>global DNA methylation [line 1-methylation (expressed as %)]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in gene-specific gene methylation</measure>
    <time_frame>baseline and after 12 months</time_frame>
    <description>After isolating DNA from whole blood, changes in methylation of targeted genes is studied (expressed as %)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in TMAO</measure>
    <time_frame>baseline and after 6 and 12 months</time_frame>
    <description>Plasma concentrations of TMAO ((µmol/L) is measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in phospholipid concentration in plasma</measure>
    <time_frame>baseline and after 12 months</time_frame>
    <description>Plasma phospholipids ((µmol/L) are measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in concentrations of bone resorption markers</measure>
    <time_frame>baseline, 6 and 12 months</time_frame>
    <description>concentrations of bone resorption markers [plasma TRAP5b (U/L), urine DPD (nmol//mmol creatinine)]: if both are increased indicate enhanced bone resorption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in plasma homocysteine concentrations</measure>
    <time_frame>baseline, 6 and 12 months</time_frame>
    <description>changes in plasma homocysteine (µmol/L) between the time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in plasma levels of folate</measure>
    <time_frame>baseline, 6 and 12 months</time_frame>
    <description>changes in serum and whole blood folate (nmol/L)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">93</enrollment>
  <condition>Nutritional Supplement Toxicity</condition>
  <arm_group>
    <arm_group_label>Vitamin D and Calcium</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>a combination of dietary supplement including &quot;all&quot; 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D, Calcium, Vitamins B9, B6, B12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a combination of dietary supplement including &quot;all&quot; 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate plus 0,5mg Folic acid, 50 mg B6, 0,5 mg B12</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D and Calcium</intervention_name>
    <description>a combination of dietary supplement including &quot;all&quot; 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate
1200 IE Vitamin D3 plus 800 mg Calcium Carbonate
Arm: Experimental: Vitamin D, Calcium, Vitamins B9, B6, B12
1200 IE Vitamin D3 plus 800 mg Calcium Carbonate plus 0,5mg Folic acid, 50 mg B6, 0,5 mg B12</description>
    <arm_group_label>Vitamin D and Calcium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D, Calcium, Vitamins B9, B6, B12</intervention_name>
    <description>a combination of dietary supplement including &quot;all&quot; 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate plus 0,5mg Folic acid, 50 mg B6, 0,5 mg B12</description>
    <arm_group_label>Vitamin D, Calcium, Vitamins B9, B6, B12</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt; 50 years,

          -  male and female

        Exclusion Criteria:

          -  renal dysfunction,

          -  recent stroke or coronary event within the last 3 months,

          -  current cancer,

          -  antifolate treatment,

          -  ileum resection,

          -  existing B vitamins supplementation,

          -  megaloblastic anemia,

          -  osteoporotic patients treated with pharmacological doses of vitamin D or
             antiosteoporotic drugs.

        Termination criteria were:

          -  indication for a high-dose vitamin B supplementation,

          -  coronary or vascular event,

          -  or surgical procedures during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rima Obeid, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saarland University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Saarland</name>
      <address>
        <city>Homburg</city>
        <state>Saarland</state>
        <zip>66424</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Kirsch SH, Herrmann W, Kruse V, Eckert R, Gräber S, Geisel J, Obeid R. One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans. Clin Chem Lab Med. 2015 Feb;53(3):445-52. doi: 10.1515/cclm-2014-0540.</citation>
    <PMID>25283139</PMID>
  </results_reference>
  <results_reference>
    <citation>Hübner U, Geisel J, Kirsch SH, Kruse V, Bodis M, Klein C, Herrmann W, Obeid R. Effect of 1 year B and D vitamin supplementation on LINE-1 repetitive element methylation in older subjects. Clin Chem Lab Med. 2013 Mar 1;51(3):649-55. doi: 10.1515/cclm-2012-0624.</citation>
    <PMID>23314556</PMID>
  </results_reference>
  <results_reference>
    <citation>Herrmann W, Kirsch SH, Kruse V, Eckert R, Gräber S, Geisel J, Obeid R. One year B and D vitamins supplementation improves metabolic bone markers. Clin Chem Lab Med. 2013 Mar 1;51(3):639-47. doi: 10.1515/cclm-2012-0599.</citation>
    <PMID>23183751</PMID>
  </results_reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2015</study_first_submitted>
  <study_first_submitted_qc>October 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2015</study_first_posted>
  <last_update_submitted>October 22, 2015</last_update_submitted>
  <last_update_submitted_qc>October 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saarland University</investigator_affiliation>
    <investigator_full_name>rima obeid</investigator_full_name>
    <investigator_title>Prof. (apl.) Dr.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

